[In the Media] Antimicrobial Resistance (AMR) Awareness Month – The Issue of Antimicrobial Resistance, The Promotion of Drug Discovery and Stable Supply (Medical Tribune, November 10, 2022)
date : 12/5/2022
Tags: AMR
![[In the Media] Antimicrobial Resistance (AMR) Awareness Month – The Issue of Antimicrobial Resistance, The Promotion of Drug Discovery and Stable Supply (Medical Tribune, November 10, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/AMRalliance-logo-11-27.jpg){kind=logo}
Health and Global Policy Institute (HGPI) has been tackling the issue of Antimicrobial Resistance (AMR) since 2016 and serves as the secretariat of AMR Alliance Japan.
On November 10, 2022, the Medical Tribune featured a media forum held on November 8 by the International Committee of the Japan Pharmaceutical Manufacturers Association (JPMA) in cooperation with the AMR Alliance Japan, entitled “Toward Antimicrobial Resistance (AMR) Awareness Month.”
For more details, please refer here.
*Available only in Japanese
**The full article can be read after logging in.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
![[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_3rd_nominations_eyecatch_caseB_ENG_web_20260929_v0.5.jpg)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
![[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261001_Eyecatch_HGPIseminer-146th-1.png)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
![[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261016_Policy-Column-2-Blood-Disorders.png)
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)
![[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/PolicyRecommendations_IntractableAndRareDiseas.jpg)
